Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Dr. Park on Alisertib in Myc-Overexpressing Lymphoma Cells

January 28th 2016

Steven I. Park, MD, director, Lymphoma Program, associate professor of Medicine, Leukemia, Lymphoma, and Myeloma Program, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Clinical Research, discusses how alisertib induces synthetic lethality and overcomes chemoresistance in Myc-overexpressing lymphoma cells.

Dr. Sekeres on Combination Therapies With Azacitidine in CMML and MDS

January 21st 2016

Mikkael A. Sekeres, MD, MS, professor of Medicine, director, Leukemia Program, Cleveland Clinic Taussig Cancer Institute, discusses a study examining azacitidine combined with lenalidomide or with vorinostat versus azacitidine monotherapy in higher-risk patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Dr. Mukherjee on Radioactive Iodine Treatment of Thyroid Cancer and Risk of MDS

January 20th 2016

Sudipto Mukherjee, MD, associate staff, Department of Hematology and Oncology, Cleveland Clinic, discusses a study examining the association between radioactive iodine treatment of thyroid cancer and the risk for developing myelodysplastic syndromes.

Dr. Mauro on Selecting Therapies for Patients With CML

January 15th 2016

Michael J. Mauro, MD, hematologist, leader of the Myeloproliferative Neoplasms Program, Leukemia Service at Memorial Sloan Kettering Cancer Center, discusses how to best select therapies for patients with chronic myeloid leukemia.

Closing Thoughts on Managing Chronic Myeloid Leukemia

January 14th 2016

Case Study: Selecting a Tyrosine Kinase Inhibitor in CML

January 14th 2016

Stem Cell Transplant in Chronic Myeloid Leukemia

January 14th 2016

Switching Therapy in Chronic Myeloid Leukemia

January 14th 2016

Managing Toxicities from CML Treatment

January 14th 2016

Chronic Myeloid Leukemia Treatment Discontinuation

January 14th 2016

Bone Marrow Assessment in CML Management

January 14th 2016

Importance of Monitoring Patients with Chronic Myeloid Leukemia

January 14th 2016

Measuring Response in Chronic Myeloid Leukemia Treatment

January 14th 2016

Upfront Treatment of Chronic Myeloid Leukemia CML

January 14th 2016

Clinical Goals of Treating CML

January 14th 2016

Mutation Analysis in Chronic Myeloid Leukemia

January 14th 2016

Multidisciplinary Team in Acute Myeloid Leukemia

January 7th 2016

Infection Prophylaxis in Acute Myeloid Leukemia

January 7th 2016

The Importance of Supportive Care in AML

January 7th 2016

Immunotherapy in Acute Myeloid Leukemia

January 7th 2016